載入...
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control
BACKGROUND: The degree of glycemic control in patients with type 2 diabetes mellitus (T2DM) may alter lipid levels and may alter the efficacy of lipid-modifying agents. OBJECTIVE: Evaluate the lipid-modifying efficacy of extended-release niacin/laropiprant (ERN/LRPT) in subgroups of patients with T2...
Na minha lista:
發表在: | Vasc Health Risk Manag |
---|---|
Main Authors: | , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Dove Medical Press
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4348131/ https://ncbi.nlm.nih.gov/pubmed/25750540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S70907 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|